Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Overweight in childhood and adolescence: Does it lead to airway hyperresponsiveness in adulthood?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Objective confirmation of asthma diagnosis improves medication adherence

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Novel monoclonal treatments in severe asthma

    Research output: Contribution to journalReviewResearchpeer-review

  1. Physiological abnormalities in patients admitted with acute exacerbation of COPD: an observational study with continuous monitoring

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. International severe asthma registry (ISAR): protocol for a global registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Airway hyperresponsiveness and airway inflammation are important hallmarks of asthma and are useful in asthma diagnosing, monitoring and treatment. The aim of the study was to assess whether two commonly used clinical tests, the mannitol challenge and Fraction of exhaled NO (FeNO), were stable clinical indicators over time in stable untreated asthmatics.

METHODS: 54 non-smoking, asthma patients not treated with steroids were enrolled in the study and assessed at baseline and a median of 6 months later. At baseline and follow-up, FeNO and airway hyperesponsiveness to mannitol were measured, and asthma control was assessed with the Asthma Control Questionnaire (ACQ).

RESULTS: A total of 41 subjects completed both visits. Mean (SD) FEV1% at baseline was 94.1% (17.7) and at re-examination 94.6% (19.7) (ns). The ACQ score was unchanged from baseline (Mean (SD): 0.90 (± 0.73)) to follow-up 0.90 (± 0.74) (ns), as was the FEV1% (94.1% (±17.1%) vs 94.6% (19.7%)(ns) indicating that patients were clinically stable during follow-up. The response to mannitol was unchanged at follow-up (Geometric mean (CI) of Response Dose Ratio (RDR) to mannitol: 0.026(0.013-0.046) vs 0.026(0.012-0.050) (ns). There was a slight decrease in FeNO at follow-up (25.5 ppb (19.7-32.9) to 21.9 ppb (17.1-28.2) (p<0.001).

CONCLUSIONS: In steroid-free non-smoking asthmatics with constant symptom scores and lung function, airway responsiveness to mannitol remained at the same level over a period of months, while a minor change in exhaled FeNO was reported. These results suggest that mannitol is a stable, reliable marker of clinical disease activity.

Original languageEnglish
JournalThe Journal of asthma : official journal of the Association for the Care of Asthma
Volume54
Issue number5
Pages (from-to)530-536
ISSN0277-0903
DOIs
Publication statusPublished - May 2017

ID: 49005470